12:00 AM
 | 
Apr 13, 2009
 |  BC Week In Review  |  Clinical News  |  Regulatory

Zegerid omeprazole tablets regulatory update

Santarus said FDA accepted for filing an NDA for a swallowable tablet formulation of Zegerid omeprazole to treat gastroesophageal reflux disease (GERD)....

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >